Picture a cutting-edge laboratory where robots operate tirelessly around the clock, autonomously conducting thousands of experiments to create materials that power the future of technology, all without a single human hand at the helm. This is no longer a vision of science fiction but a reality
For decades, the commercial spotlight in biopharma has shone the brightest on high-prevalence conditions—diabetes, heart disease, and oncology. But a quieter revolution is unfolding in the rare disease space, where smaller patient populations are redefining how value is created. Behind every
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, as well as a deep understanding of technology and innovation in the industry. Today, we’re diving into the heartbreaking case of Leticia Paul, a young lawyer who
Imagine a crime scene where a single drop of blood holds the key to identifying a suspect, not just by DNA but by estimating their age with remarkable precision, a technique that has become invaluable in modern investigations. Forensic age estimation tools, relying on DNA methylation patterns, have
Drug discovery has long been a daunting endeavor, with the staggering statistic that developing a single new drug can cost upwards of $1 billion and take over a decade to reach the market. Imagine a world where this timeline is slashed, costs are dramatically reduced, and even smaller research
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, as well as a deep understanding of technological innovation in the industry. Today, we’re diving into the recent European Commission approval of Cabometyx for advanced
In an era where technology and biology are increasingly intertwined, imagine a world where the painstaking process of optimizing cell culture media—a cornerstone of biopharmaceutical and regenerative medicine research—is revolutionized by artificial intelligence. Machine learning, once confined to
Imagine a world where the simple act of lifting a spoon to eat or brushing one’s hair becomes an insurmountable challenge due to mobility impairments caused by conditions like amyotrophic lateral sclerosis (ALS) or stroke. For millions globally, this is a daily reality, but a groundbreaking
Imagine a world where a diagnosis of multiple myeloma (MM), a devastating blood cancer affecting over 180,000 people globally each year, no longer feels like an insurmountable challenge. With relapse rates stubbornly high and no definitive cure in sight, the urgency for groundbreaking treatments
In the rapidly evolving landscape of healthcare technology, Tempus AI (TEM) stands out as a trailblazer in precision oncology, harnessing the power of artificial intelligence to reshape how cancer is diagnosed and treated, and with a market capitalization of $12.8 billion as of the second quarter
